Common Contracts
1 similar Supply Agreement contracts
AMENDMENT No. 2 to the SUPPLY AGREEMENT between Novartis Pharma AG and CMS Pharma Co., Ltd.Supply Agreement • October 18th, 2017
This Amendment No. 2 (“Amendment No. 2”) to the Supply Agreement of December 17th, 2014 (as amended and supplemented by Amendment No. 1 dated January 26th, 2017 (“Amendment No. 1”)) for Parlodel and Lamisil (“Supply Agreement”) is entered into as of October 20th, 2017 (“Second Amendment Effective Date”) by and between Novartis Pharma AG, a Swiss corporation having its principal place of business at Lichtstrasse 35, 4056, Basel, Switzerland (“Novartis”) and CMS Pharma Co., Ltd., a company organized under the laws of Malaysia and located at Level 15(A2), Main Office Tower, Financial Park Labuan Jalan Merdeka, 87000 Labuan F.T. Malaysia (“Purchaser”). Novartis and Purchaser are each referred to individually as a “Party” and together as the “Parties”.
